From the brink 21 years ago, IVP now stronger than ever

The late-stage investor announced in early October that its 116th portfolio company, telemed start-up Hims & Hers, will go public via a SPAC. But IVP’s future was not always as clear.

ManagersFeatured SliderPeople - Firms